Iridex (IRIX) Operating Income (2010 - 2026)
Iridex's (IRIX) quarterly Operating Income came in at -$324000.0 in Q2 2026, down 58.05% year-on-year from -$772325.6 in Q2 2025, and down 2060.0% quarter-over-quarter from -$15000.0 in Q1 2026.
Iridex (IRIX) Operating Income (2010 - 2026) Analysis & Trends
Iridex's Operating Income history runs 17 years deep, the most recent figure standing at -$324000.0 for Q2 2026.
- On a quarterly basis, Operating Income fell 58.05% year-over-year to -$324000.0 in Q2 2026; TTM through Apr 2026 was -$2.7 million, a 48.42% increase from a year earlier, with the FY2026 full-year figure at -$2.6 million, up 69.03% from the prior year.
- Operating Income fell to -$324000.0 in Q2 2026 per IRIX's latest filing, from -$15000.0 in the prior quarter.
- Across five years, Operating Income topped out at -$15000.0 in Q1 2026 and bottomed at -$3.3 million in Q1 2024.
- The 5-year median for Operating Income is -$1.7 million (2022), against an average of -$1.7 million.
- Across the five-year window, Operating Income sank 118.51% in 2023 and surged 97.01% in 2026, its largest moves.
- Year by year, Operating Income stood at -$1.4 million in 2022, then sank by 118.51% to -$3.1 million in 2023, then jumped by 83.71% to -$502000.0 in 2024, then plunged by 181.08% to -$1.4 million in 2025, then soared by 77.04% to -$324000.0 in 2026.
- Per Business Quant, the three latest IRIX Operating Income figures stand at -$324000.0 (Q2 2026), -$15000.0 (Q1 2026), and -$1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | -324,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -324,000.00 |
| Jan 3, 2026 | -15,000.00 |
| Sep 27, 2025 | -1.41 Mn |
| Jun 28, 2025 | -940,000.00 |
| Mar 29, 2025 | -205,000.00 |
| Dec 28, 2024 | -502,000.00 |
| Sep 28, 2024 | -1.87 Mn |
| Jun 29, 2024 | -2.64 Mn |
| Mar 30, 2024 | -3.29 Mn |
| Dec 30, 2023 | -3.08 Mn |
| Sep 30, 2023 | -1.69 Mn |
| Jul 1, 2023 | -2.89 Mn |
| Apr 1, 2023 | -2.34 Mn |
| Dec 31, 2022 | -1.41 Mn |
| Oct 1, 2022 | -1.70 Mn |
| Jul 2, 2022 | -2.16 Mn |
| Apr 2, 2022 | -2.28 Mn |
| Jan 1, 2022 | -1.25 Mn |
| Oct 2, 2021 | -2.16 Mn |
| Jul 3, 2021 | -1.14 Mn |